Biotage AB (publ) (BIOT.ST)
| Previous Close | 160.70 |
| Open | 160.70 |
| Bid | 160.80 x 0 |
| Ask | 161.30 x 0 |
| Day's Range | 157.80 - 162.50 |
| 52 Week Range | 104.60 - 202.20 |
| Volume | |
| Avg. Volume | 60,748 |
| Market Cap | 13.552B |
| Beta (5Y Monthly) | 0.85 |
| PE Ratio (TTM) | 48.73 |
| EPS (TTM) | 3.30 |
| Earnings Date | Oct 23, 2024 |
| Forward Dividend & Yield | 1.60 (1.00%) |
| Ex-Dividend Date | Apr 26, 2024 |
| 1y Target Est | 210.75 |
- GuruFocus.com
Biotage AB (BITGF) Q3 2024 Earnings Call Highlights: Strong Organic Growth Amidst Market Challenges
Biotage AB (BITGF) reports robust organic growth and strategic investments, despite facing production constraints and regional market pressures.
Simply Wall St.3 Swedish Stocks Estimated To Be Trading Below Intrinsic Value In October 2024
As the European Central Bank's recent interest rate cuts fuel expectations for further monetary easing, Sweden's stock market is experiencing a period of heightened investor interest. In this environment, identifying stocks that are trading below their intrinsic value can be particularly appealing to investors looking for opportunities amidst broader economic shifts.
Simply Wall St.Three Swedish Stocks Estimated To Be Trading Below Intrinsic Value
As global markets respond to China's stimulus measures and European indices show signs of recovery, Sweden's economic landscape is also experiencing shifts, highlighted by the Riksbank's recent interest rate cut. In this context, investors are increasingly looking for opportunities in stocks that may be trading below their intrinsic value, offering potential for growth as market conditions stabilize. Identifying such undervalued stocks involves assessing factors like strong fundamentals and...
